Stuart J. Connolly, Clinical Trialist and Arrhythmia Medicine Pioneer, Dies at 75 tctmd.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tctmd.com Daily Mail and Mail on Sunday newspapers.
For patients who had taken factor Xa inhibitors within 15 hours before having an acute intracerebral hemorrhage, andexanet alfa, which reverses the effects of factor Xa inhibitors, results in better control of hematoma expansion than usual care, according to a study published in the New England Journal of Medicine.
Dr Connolly highlights the cautious patient selection and the significance of reducing hematoma expansion for improved outcomes in cases of intracerebral hemorrhage (ICH) associated with the use of a reversal agent for factor Xa inhibitors.
The FDA has approved the first-ever IV iron replacement therapy to improve exercise capacity in adults with heart failure. The IV ferric carboxymaltose injection (Injectafer; Daiichi Sankyo Inc./American Regent) was approved for patients with New York Heart Association class II/III heart failure, which is defined as a slight or marked limitation of physical activity due to fatigue, palpitation